Industry Experts

Sarav Narayanan is an experienced biopharma leader with over 12 years of expertise in biologics drug discovery across oncology and inflammation. He has held key roles at Takeda and Biogen, where he led and advanced multiple high-impact programs to IND and clinical milestones. As an Associate Scientific Director at Takeda, Sarav has been instrumental in shaping successful in- and out-licensing strategies, driving due diligence efforts, and developing robust in-vitro pharmacology and analytics frameworks for diverse modalities such as ADC/AOC, bispecifics, and CAR-T. Sarav holds a PhD in Biochemistry from TU Munich, Germany, and completed his postdoctoral training as a Harvard-Lefler Research Fellow at Harvard Medical School.